Nuwellis, Inc. Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
December 08 2022 - 8:10AM
Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused
on transforming the lives of people with fluid overload, today
announced that the Company’s Special Meeting of Stockholders, on
December 7, 2022 at 2:00 p.m. (CST), was convened and adjourned,
without any business being conducted, due to lack of the required
quorum.
A quorum consists of one-third of the outstanding shares
entitled to vote. There were fewer than one-third of outstanding
shares entitled to vote, either present virtually or represented by
proxy, at the Special Meeting. The Special Meeting therefore had no
quorum and was adjourned to 2:00 p.m. Central Time on January 4,
2023 at www.viewproxy.com/nuwesm/2022 to allow additional time for
the Company’s stockholders to vote on the proposals set forth in
the Company’s definitive proxy statement filed with the Securities
and Exchange Commission on November 7, 2022.
During the period of adjournment, the Company will continue to
solicit votes from its stockholders with respect to the proposals
set forth in the proxy statement.
Only stockholders of record as of the record date, October 13,
2022, are entitled to and are being requested to vote. At the time
the Special Meeting was adjourned, proxies had been submitted by
stockholders representing approximately 31.69% of the shares of the
Company’s common stock outstanding and entitled to vote at the
Special Meeting. Proxies previously submitted in respect of the
Special Meeting will be voted at the adjourned Special Meeting
unless properly revoked, and stockholders who have previously
submitted a proxy or otherwise voted need not take any action.
The Company encourages all stockholders of record on October 13,
2022 who have not yet voted to do so before Tuesday, January 3,
2023 at 10:59 p.m., Central Time.
Important InformationThis
material may be deemed to be solicitation material in respect of
the Special Meeting to be reconvened and held on Wednesday, January
4, 2023. In connection with the Special Meeting, the Company filed
a definitive proxy statement with the SEC on November 7, 2022.
BEFORE MAKING ANY VOTING DECISIONS, STOCKHOLDERS ARE URGED TO READ
THE DEFINITIVE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS
FILED WITH THE SEC, BECAUSE THEY CONTAIN IMPORTANT INFORMATION
ABOUT THE SPECIAL MEETING. The definitive proxy statement was
mailed to stockholders who are entitled to vote at the Special
Meeting. No changes have been made in the proposals to be voted on
by stockholders at the Special Meeting. The Company’s proxy
statement and any other materials filed by the Company with the SEC
can be obtained free of charge at the SEC’s website at sec.gov or
at www.proxyvote.com.
About NuwellisNuwellis, Inc.
(Nasdaq: NUWE) is a medical technology company dedicated to
transforming the lives of patients suffering from fluid overload
through science, collaboration, and innovation. The company is
focused on developing, manufacturing, and commercializing the
Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is
headquartered in Minneapolis, Minnesota, with a wholly owned
subsidiary in Ireland.
About the Aquadex SmartFlow
SystemThe Aquadex SmartFlow system delivers clinically
superior therapy using a simple, flexible and smart method of
removing excess fluid from patients suffering from hypervolemia
(fluid overload). The Aquadex SmartFlow system is indicated for
temporary (up to 8 hours) or extended (longer than 8 hours in
patients who require hospitalization) use in adult and pediatric
patients weighing 20 kg or more whose fluid overload is
unresponsive to medical management, including diuretics. All
treatments must be administered by a health care provider, within
an outpatient or inpatient clinical setting, under physician
prescription, both having received training in extracorporeal
therapies.
CONTACTS
INVESTORS:Vivian CervantesGilmartin Group
LLCir@nuwellis.com
Newellis (NASDAQ:NUWE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Newellis (NASDAQ:NUWE)
Historical Stock Chart
From Apr 2023 to Apr 2024